Isopropyl Alcohol Infiltration in Modern IVF Labs: A Review of Persistent Airborne Toxins
Poster Presentation, ASRM | Oct 2024 | Orsolini, M., Schenkman, E., Russack, J., Huynh, H., Schust, D., Raburn, D., Worrilow, K.C., and Fox., J.T.
Poster Presentation, ASRM | Oct 2024 | Orsolini, M., Schenkman, E., Russack, J., Huynh, H., Schust, D., Raburn, D., Worrilow, K.C., and Fox., J.T.
Applied In Vitro Toxicology 11, no. 4 | 2025 | Russack, J. S., J. T. Fox, H. T. Huynh, K. C. Worrilow, and D. G. Brown.
Poster Presentation, ASRM | Oct 2025 | Russack, J., Huynh, H., Urrutia, A., and Worrilow, K.C.
CRC Press | 21 Mar, 2024 | Chapter 2 written by Kathryn C. Worrilow and Alicia R. Urrutia
A peer-reviewed study published in Science and Technology for the Built Environment examining the clinical and environmental effects of LifeAire’s advanced air purification technology across multiple healthcare settings — an acute care hospital and a long-term care facility. The study synthesizes environmental and clinical outcome data from both settings, demonstrating that LifeAire’s multi-stage system, designed to inactivate the genetic material of all airborne pathogens and remediate volatile organic compounds, produced consistent, measurable improvements across both facility types. Originally presented at the 2022 ASHRAE Annual Conference in Toronto. Published in Science and Technology for the Built Environment, Volume 29, Issue 9, October 2023. DOI: 10.1080/23744731.2023.2266349. Authors: Urrutia, A.R.; Stawicki, S.P.; Kimble, C.N.; Worrilow, K.C.
A peer-reviewed short commentary published in the Journal of Gerontology and Geriatric Medicine examining the clinical and economic outcomes of LifeAire’s advanced air purification technology in a long-term care facility over 15 months. The study compared LifeAire’s multi-stage system — combining VOC filtration, high-dose UV germicidal irradiation, and HEPA filtration — against standard HEPA filtration in a memory support unit. Documented outcomes included a 98.83% reduction in airborne pathogens, an 89.88% reduction in VOC levels, a 39.6% reduction in facility-acquired infections, and a 47% reduction in staff call-outs. The findings demonstrate meaningful improvements in resident wellness, safety, and facility economics. Published in Journal of Gerontology and Geriatric Medicine, July 2023. DOI: 10.24966/GGM-8662/100177. Authors: Urrutia, A.R.; Eid, S.; Bock, K.A.; Worrilow, K.C.
Amazon | Sandro C. Esteves, Alex C. Varghese, Kathryn C. Worrilow
A peer-reviewed, IRB-approved study examining the impact of LifeAire’s advanced air purification technology on environmental and clinical outcomes in a long-term care memory support facility over a 15-month period. The study compared a LifeAire-protected unit with a HEPA-only control unit on the same floor, measuring airborne and surface pathogen burden, facility-acquired infection rates, and staff absenteeism. Documented outcomes in the LifeAire-protected unit included an 89.1% reduction in airborne pathogens, an 88.9% reduction in surface pathogens, a 39.6% reduction in facility-acquired infections, and a 47% reduction in staff call-outs. The findings confirm that advanced air purification delivers measurable improvements in both clinical outcomes and operational performance in long-term care environments. Published in The Journals of Gerontology: Series A, Volume 78, Issue 12, 2023. Authors: Urrutia, A.R.; Schlener, S.D.; Eid, S.; Bock, K.A.; Worrilow, K.C.
A peer-reviewed, IRB-approved operational clinical study examining the impact of LifeAire’s advanced air purification technology on airborne and surface pathogen burden, hospital-acquired infection rates, patient length of stay, and healthcare economics. Conducted at St. Luke’s University Health Network, the study compared a LifeAire-protected unit with a HEPA-only control unit over 12 months across 8,255 patients. Documented outcomes in the protected unit included a 99.99% reduction in viable airborne pathogens, a 97% reduction in surface pathogens, a 30% reduction in hospital-acquired infections, a 39% reduction in patient length of stay, and a 23% improvement in per-bed economics. Published in the Journal of Global Infectious Diseases, March 2023.
A peer-reviewed conference abstract examining the impact of LifeAire’s advanced air purification technology on environmental and clinical outcomes in a long-term care facility. The study deployed LifeAire’s system in a memory support unit and compared environmental and clinical metrics against a HEPA-only control unit on the same floor. The technology, designed to destroy the DNA and RNA of all bacteria, fungi, and viruses on a single pass while also remediating volatile organic compounds, produced measurable improvements in airborne and surface pathogen burden, facility-acquired infection rates, and staff absenteeism. Published in Innovation in Aging, Volume 5, Supplement 1, December 2021. Presented at the Gerontological Society of America Annual Meeting. Authors: Schlener, S.D.; Urrutia, A.R.; Worrilow, K.C.; Bock, K.
